an intermediate in the Krebs cycle
an intermediate in the Krebs cycle
BCAA metabolite
BCAA metabolite
BCAA metabolite
BCAA metabolite
BCAA metabolite
BCAA metabolite
BCAA metabolite
DDT, a persistent organic pollutant once commonly used as a pesticide for controlling malaria and typhus, metabolizes in humans to produce 2,2-bis (4-chlorophenyl) acetic acid (DDA), the primary urinary metabolite and potential exposure biomarker. DDT readily adsorbs to soils and sediments, which can serve as both sinks and long-term sources of exposure. As an endocrine disruptor, DDT poses significant health risks, potentially disrupting semen quality, menstruation, gestational length, and lactation duration, and accumulating in lipid-rich areas of the body, affecting reproductive capabilities and fetal development. It is also likely a human carcinogen, particularly linked to breast cancer. DDE, another DDT metabolite, is excreted as DDA in the urine. Humans can absorb DDT through inhalation of gaseous and particulate phases, direct dermal contact, ingestion of contaminated substances, and exposure to contaminated soil or products. To detoxify, sweating induced by infrared and steam sauna sessions can help eliminate DDT from the body by excreting it through the skin.
2,3-dinor-11β-Prostaglandin F2α (urine) is a stable downstream metabolite of prostaglandin D2 (PGD2)—a mast-cell–derived lipid mediator—measured in spot or 24-hour urine (typically by LC-MS/MS and normalized to creatinine) to provide a noninvasive index of in-vivo PGD2 production and mast-cell activation. Elevated values, interpreted against the lab’s own reference range, can support conditions with mediator release such as mast cell activation syndrome or systemic mastocytosis, allergic reactions and anaphylaxis, aspirin/NSAID-exacerbated respiratory disease, atopic asthma, allergic rhinitis, and chronic spontaneous urticaria; however, it is a supportive—not standalone—marker and should be correlated with symptoms and companion tests (e.g., serum tryptase—including event-related rise of baseline +20%+2 ng/mL—urinary N-methylhistamine, and urinary leukotriene E4). Results are time-sensitive to flares (collect as close to symptoms as possible), and medications can shift levels: NSAIDs/COX-2 inhibitors often suppress prostaglandin synthesis; corticosteroids and mast-cell stabilizers may lower levels over time; biologics and leukotriene modifiers can alter patterns. Normal results do not exclude mast-cell activation due to intermittent release; very low levels may reflect COX inhibition or effective therapy. For trending, use the same lab/method, verify units (e.g., pg/mg creatinine), and document a baseline and flare sample when feasible.
a very common herbicide
2,4-Dichlorophenoxyacetic Acid (2,4-D) Parent Compound: 2,4-Dichlorophenoxyacetic Acid (2,4-D) 2,4-Dichlorophenoxyacetic Acid, commonly known as 2,4-D, is one of the most widely used herbicides globally, particularly in agricultural and landscaping applications. It is used to control broadleaf weeds in a variety of crops, lawns, and public spaces. Despite its effectiveness as a weed control agent, concerns have arisen regarding its potential health risks, particularly from chronic exposure. Exposure and Uses 2,4-D is primarily used in agriculture for weed management in crops such as corn, wheat, and rice, as well as in non-crop areas like golf courses, lawns, and roadsides. It is often applied through spraying, which leads to both direct exposure for those applying the herbicide and indirect exposure through the surrounding environment. Health Risks of 2,4-D Exposure Chronic or long-term exposure to even low levels of 2,4-D has been linked to several adverse health effects, making its detection an important biomarker in assessing exposure risks. Endocrine Disruption: There is evidence suggesting that 2,4-D may interfere with hormone systems in the body, particularly by disrupting thyroid and estrogenic activity. This disruption can lead to a variety of health issues, including developmental and reproductive effects. Reproductive Effects: Studies have raised concerns about the impact of 2,4-D on fertility and reproduction, particularly in men and women exposed to higher levels over time. Exposure may lead to hormonal imbalances, which could affect fertility. Developmental Effects: In utero exposure to 2,4-D has been associated with potential developmental issues, including increased risks of birth defects. Although evidence is still under investigation, some studies suggest that early-life exposure to this herbicide could affect fetal development. Increased Risk of Non-Hodgkin Lymphoma: Long-term exposure to 2,4-D has been linked to an elevated risk of certain cancers, particularly non-Hodgkin lymphoma (NHL). This connection is particularly concerning for individuals in agricultural professions who have prolonged and repeated exposure to the chemical. 2,4-D as a Biomarker of Exposure The presence of 2,4-D in the body can be detected through its metabolites in biological samples like urine. Elevated levels of 2,4-D can indicate recent or chronic exposure to the herbicide, making it an important marker for assessing potential health risks. Biomarker testing for 2,4-D exposure can help determine if individuals are at increased risk for the health effects associated with the chemical. Conclusion While 2,4-D is effective as a weed management tool, its potential health risks from chronic exposure are significant. These risks include endocrine disruption, reproductive and developmental issues, and an increased likelihood of certain cancers, especially non-Hodgkin lymphoma. Monitoring exposure through biomarkers like 2,4-D levels can help individuals identify potential risks and take preventive actions to reduce exposure.
An optimal 2/16α ratio falls between 2 and 4. Ratios below 2 may suggest an increased risk of breast cancer, though this concern is less significant when overall estrogen levels are low. Supporting estrogen metabolism toward 2-OH E1 with targeted nutrients may be beneficial in such cases. Ratios above 4, particularly when 16α-OH E1 levels are low, may indicate an elevated risk of osteopenia.
a metabolite of progesterone
related to autoimmune Addison's disease